1989
DOI: 10.1001/jama.1989.03420020117041
|View full text |Cite
|
Sign up to set email alerts
|

Representation of American Blacks in Clinical Trials of New Drugs

Abstract: Investigations that have revealed racial differences in drug response and disposition indicate the need for adequate representation of racial minorities in clinical drug trials. There is concern, however, that there may be a disproportionate use of racial and ethnic minorities in clinical research due to the inner city location of most university hospitals. To examine this issue, we reviewed the representation of American blacks in 50 recently published clinical trials of new drugs. This survey revealed that i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
36
0

Year Published

1990
1990
2012
2012

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 120 publications
(36 citation statements)
references
References 8 publications
0
36
0
Order By: Relevance
“…In fact, only 58% of these studies reported race/ethnicity of enrolled subjects versus 91% reporting gender and 80% reporting age. This represents an improvement, however, over an earlier review finding that only 20% of 50 published clinical trials of new drugs included any racial data (103). In some areas of research, particularly prevention studies involving relatively healthy volunteers, reporting of sample race/ethnicity is even less common.…”
Section: Methodsmentioning
confidence: 93%
“…In fact, only 58% of these studies reported race/ethnicity of enrolled subjects versus 91% reporting gender and 80% reporting age. This represents an improvement, however, over an earlier review finding that only 20% of 50 published clinical trials of new drugs included any racial data (103). In some areas of research, particularly prevention studies involving relatively healthy volunteers, reporting of sample race/ethnicity is even less common.…”
Section: Methodsmentioning
confidence: 93%
“…Although there are safeguards in place to protect subjects in human experimentation, these measures have not erased the fear among many African Americans that they will be abused for the sake of medical research (Gamble 1993). This fear of medical research has contributed to the low participation rates and subsequent under-representation of African Americans in clinical trials (King, 1992;Sevensson, 1989;Smith, 1991). However, successful recruitment of African Americans into research has been done and is possible.…”
Section: Subject Recruitmentmentioning
confidence: 99%
“…People of color and low-income people have been historically underrepresented in clinical trials, thus bringing into question the applicability of the results of those trials to the patients we treat. 24,25 Enrolling more CHC patients in clinical trials would greatly enhance the state of clinical information available in the United States.…”
Section: Role Of Community Health Centers In Advancing Knowledge How mentioning
confidence: 99%